Atrium Therapeutics, Inc. (RNA)
NASDAQ·Healthcare·Biotechnology
$8.22
-1.50%
Mkt Cap $142.49M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+204.3%
Consensus $25.00 vs current $8.22
NASDAQ·Healthcare·Biotechnology
$8.22
-1.50%
Mkt Cap $142.49M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
+204.3%
Consensus $25.00 vs current $8.22